BIOAVAILABILITY OF METRONIDAZOLE IN FASTING AND NON-FASTING HEALTHY SUBJECTS AND IN PATIENTS WITH CROHNS-DISEASE

被引:34
作者
MELANDER, A
KAHLMETER, G
KAMME, C
URSING, B
机构
[1] UNIV LUND,LUND UNIV HOSP,DEPT CLIN PHARMACOL,S-22007 LUND 7,SWEDEN
[2] UNIV LUND,LUND UNIV HOSP,DEPT MED MICROBIOL,S-22007 LUND 7,SWEDEN
[3] UNIV LUND,LUND UNIV HOSP,DEPT INFECT DIS,S-22007 LUND 7,SWEDEN
[4] COMMUN CARE SCI UNIT,DALBY,SWEDEN
关键词
D O I
10.1007/BF00561408
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:69 / 72
页数:4
相关论文
共 9 条
  • [1] MELANDER A, 1976, ACTA MED SCAND, V200, P497
  • [2] MELANDER A, 1976, ACTA MED SCAND, V200, P93
  • [3] MELANDER A, 1977, ACTA MED SCAND, V201, P41
  • [4] MELANDER A, IN PRESS
  • [5] PARSONS RL, 1976, CHEMOTHERAPY, V4, P219
  • [6] PHARMACOKINETICS OF METRONIDAZOLE AS DETERMINED BY BIOASSAY
    RALPH, ED
    CLARKE, JT
    LIBKE, RD
    LUTHY, RP
    KIRBY, WMM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1974, 6 (06) : 691 - 696
  • [7] SCHWARTZ DE, 1976, CHEMOTHERAPY, V22, P19
  • [8] URSING B, 1975, LANCET, V1, P775
  • [9] URSING B, 1975, EXCERPTA MEDICAL 386, P189